Drug Profile
Human krebs statika
Latest Information Update: 14 Oct 1994
Price :
$50
*
At a glance
- Originator Yamanouchi
- Class Antineoplastics
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.